Back to Agenda
Session 1 Plenary: Strategic Insights from Latin America Authorities
Session Chair(s)
Flavia Firmino, PHARMD
Regulatory Policy Lead - Latin America, Eli Lilly and Company, Brazil
Rosana M. Mastellaro, PHARMD, RPH
Director, Technical Regulatory Affairs and Innovation, Sindusfarma, Brazil
This session will provide the latest regulatory updates from national regulatory authorities from Latin America, including projects, priorities, and initiatives in the short and medium term, and delve into the priorities that dominate the regulatory agenda, shedding light on the strategic goals and objectives set forth by LATAM authorities. Attendees will gain valuable insights into the plans that are being formulated to address emerging challenges and opportunities within the regulatory framework.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Gain an understanding of the key priorities that dominate the current regulatory agenda set by LATAM authorities
- Explore the specific strategic goals and objectives that have been established to guide regulatory efforts in the region
- Explore opportunities for collaboration among public, private, and academic sectors to advance regulatory agendas and promote regulatory harmonization
Speaker(s)
Strategic Perspectives of Latin American Authorities
Professional from the National Institute of Drugs, ANMAT Ministry of Health, Argentina
Strategic Insights from ANVISA
Associate Director of the 3rd Directorate, Brazilian Health Regulatory Agency (ANVISA), Brazil
Strategic Perspectives of the Sanitary Regulation Superintendency of El Salvador
Head of the Operations Office for the Registration and Market Authorizations Int, Sanitary Regulation Superintendency, El Salvador
Speaker
Head of Marketing Authorization for Biological Products, Institute of Public Health of Chile, Chile
Speakers
Risk Profile Technical , ARCSA, Ecuador
Have an account?